<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib5">
 <label>5</label>
 <element-citation publication-type="journal" id="sbref50">
  <person-group person-group-type="author">
   <name>
    <surname>Stephenson</surname>
    <given-names>KE</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>CS</given-names>
   </name>
   <name>
    <surname>Walsh</surname>
    <given-names>SR</given-names>
   </name>
  </person-group>
  <article-title>Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial</article-title>
  <source>Lancet Infect Dis</source>
  <year>2020</year>
  <comment>published online May 6.</comment>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30085-2</pub-id>
 </element-citation>
</ref>
